Skip navigation Company Investor relations Press Contact DE EN FIRST MOVER in the billion euro market Aesthetic treatments have become an accepted part of society, growing into a billion dollar market... Previous Next WachstumskursWachstumspotenzial Skip navigation COMPANY INVESTOR RELATIONS INVESTOR NEWS CONTACT SUCCEEDING WITH WORLD-CLASS MEDICINE M1 Kliniken AG Medical Care For a Better Life – with this vision M1 Kliniken AG, one of the fastest growing healthcare services providers in Germany, has developed an innovative concept, which offers affordable access to beauty treatments at highest qualitative standards. INVESTOR RELATIONS M1 KLINIKEN AG M1 stock ISIN: DE000A0STSQ8 | WKN: A0STSQ | Ticker symbol: M12 Title name: Bearer Share Number of shares: 19.643.403 Stock exchange: Frankfurt, Stuttgart, Berlin, Düsseldorf, München, Hannover, Xetra, Hamburg, Tradegate Exchange Market segment: Open Market Designated Sponsoring: Kepler Cheuvreux Inital trading day: 14.09.2015 More information 18.11.2021 | INVESTOR NEWS M1 Kliniken AG publishes figures for the 3st quarter of 2021 Group revenue rises to EUR 237 million (EUR 82 million in Q3-2020) Beauty: treatment numbers at high level; record revenue in German practice network in October 2021; no negative impact from rising incidence rate of the Corona pandemic Group EBITDA amounts to EUR 13.3 million (previous year: EUR 8.8 million); EBIT amounts to EUR 9.1 million (previous year: EUR 5.8 million); EBIT margin in the German practice network in the target corridor of 15-20% despite large number of new openings Read more … M1 Kliniken AG publishes figures for the 3st quarter of 2021 20.09.2021 | INVESTOR NEWS M1 Kliniken AG continues growth course Significant expansion of site capacities in Germany and internationally Sales in the "Beauty" segment well above the previous year's figures. Expected annual sales of over EUR 50 million in the Beauty segment in 2021 Read more … M1 Kliniken AG continues growth course 25.08.2021 | INVESTOR NEWS M1 Kliniken AG announces its financials for the 1st half of 2021 Group revenue rises to just under EUR 165 million (EUR 37 million in H1- 2020) Consolidated EBITDA amounts to EUR 9.9 million (previous year: EUR 1.7 million); EBIT amounts to EUR 7.1 million (previous year: EUR -0.05 million) Beauty: Significant increase in treatment and sales figures; Coronarelated ‘idle capacity’ due to vaccination intervals Read more … M1 Kliniken AG announces its financials for the 1st half of 2021 CONTACT M1 Kliniken AG Grünauer Straße 5 12557 Berlin Germany T. +49 (0) 30 347 47 44 14 F. +49 (0) 30 347 47 44 17 ir@m1-kliniken.de Contact us © 2021 M1 Kliniken AG Nach oben Skip navigation Imprint Data protection declaration Disclaimer Sitemap Cookie settings We use cookies on our website. Some of them are essential, while others help us to improve this website and your experience. Essential Show details Third-party content Show details SAVE SELECTION ACCEPT ALL By using this website, you consent to the use of cookies. You can find detailed information on the use of cookies on this website in the data protection declaration. Imprint Data protection declaration